Inhiprot

InhiProt is a start-up biotech company that aims to develop novel treatments for multiple myeloma, an incurable cancer of bone marrow.

Call 2017

Call for applications open.

Apply

@YeiAccelerator

Newsletter

Receive notifications about the YEi Start in France program (Call for applications, announcement of the laureates, YEi events, etc.)

Social Links